Just a few years ago, single-cell analyses were complex and not user-friendly. Now, thanks to professionalised workflows, the technology is finding its way into the industry. European Biotechnology spoke with Dr Michael Schnall-Levin, SVP R&D, Founding Scientist, from market leader 10X Genomics about the increasing importance of capturing cell heterogeneity for biomedical research.
Rheincell set to be acquired by Catalent
Latest NewsMajor CDMO Catalent has swallowed German RheinCell Therapeutics GmbH, an iPSC specialist, to expand its offerings in cell and gene therapies.
Data protection rules may block medical progress
Latest NewsIn an effort to ban AI tools for facial recognition, the EU risks to block European medical geneticists to recognise genetic diseases.
AFB strengthens finance division
AppointmentsAt the beginning of June, Sidonie Fabre strengthens Advent France Biotechnology (AFB) as new Chief Financial Officer.
NeuVasQ Biotechnologies bags €20m in Series A financing
Latest NewsNeuVasQ Biotechnologies has raised €20m through a Series A investment to advance its technology platform that restores the integrity of the blood-brain barrier in acute neurological disorders.
Coriolis Pharma expands its ATMP development facilities
Latest NewsCoriolis Pharma will launch operations at its currently expanded ATMP development facilities by Q4/2021.
Tube welding or aseptic connectors Which is the better connection method?
Sponsored PublicationsWhich connection method do most industry professionals prefer: tube welding or aseptic connectors? A recent survey revealed their preferences are almost equally split between the two. But that doesn’t mean one method might not be better for your needs.
First German Evotec BRIDGE in Heidelberg
Sponsored PublicationsOn 13 April 2021, Evotec SE launched beLAB2122 in collaboration with Bristol-Myers Squibb company and five top-tier academic institutions. Mediated and supported by BioRN Life Science Cluster Rhine-Neckar, this $20 million BRIDGE brings together leading academic institutions in Southwestern Germany with the goal of efficiently advancing novel drug discovery projects.
Including China in your global drug development strategy
Sponsored PublicationsThe pandemic showed us that we need to establish safety and effectiveness across different populations for a universally effective vaccine, including China. And, following Covid-19 development, we noted an instant increase in clinical trials conducted in China. So, why exactly is China an attractive market to consider for drug development strategies?
mRNA: Evonik cooperates with Stanford University
Latest NewsCompany seeks new opportunities for use of mRNA therapeutics.
Accelerate single cell analyses in industry and academia
Sponsored PublicationsJust a few years ago, single-cell analyses were complex and not user-friendly. Now, thanks to professionalised workflows, the technology is finding its way into the industry. European Biotechnology spoke with Dr Michael Schnall-Levin, SVP R&D, Founding Scientist, from market leader 10X Genomics about the increasing importance of capturing cell heterogeneity for biomedical research.